Recombinant Nitrosomonas europaea 50S ribosomal protein L29 (rpmC)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Nitrosomonas europaea 50S Ribosomal Protein L29 (rpmC)

Recombinant Nitrosomonas europaea 50S ribosomal protein L29, encoded by the rpmC gene, is a crucial component of the bacterial ribosome. This protein is part of the large 50S subunit, which plays a vital role in protein synthesis by catalyzing peptide bond formation. The recombinant form of this protein is produced through genetic engineering techniques, allowing for its expression in host organisms like Escherichia coli.

Function and Importance

Ribosomal protein L29 belongs to the universal ribosomal protein uL29 family and is involved in binding to 23S rRNA, which is essential for the structural integrity and function of the ribosome . Although it is not essential for bacterial growth, its presence is crucial for efficient ribosome assembly and function .

Research Findings

Recent studies on bacterial ribosomes have highlighted the complex assembly process of the 50S subunit. This process involves multiple parallel pathways and requires specific assembly factors to ensure proper maturation of the ribosomal particles . While specific research on Nitrosomonas europaea 50S ribosomal protein L29 is limited, studies on similar proteins in other bacteria provide valuable insights into its potential roles and interactions.

Recombinant Production

Recombinant proteins are produced using molecular biology techniques where the gene encoding the protein of interest is inserted into a plasmid and expressed in a host organism. For Nitrosomonas europaea 50S ribosomal protein L29, this would typically involve cloning the rpmC gene into an expression vector and transforming it into Escherichia coli or another suitable host.

Table 2: Comparison with Human 60S Ribosomal Protein L29

FeatureNitrosomonas europaea 50S L29Human 60S L29 (RPL29)
Subunit50S (bacterial)60S (eukaryotic)
FunctionEssential for ribosome assemblyComponent of 60S subunit
Binding23S rRNAPeripheral membrane protein, binds heparin

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rpmC; NE0409; 50S ribosomal protein L29
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-64
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Nitrosomonas europaea (strain ATCC 19718 / CIP 103999 / KCTC 2705 / NBRC 14298)
Target Names
rpmC
Target Protein Sequence
MKVQELREKN LSELGKELLS LRRAQFGLRL QHRTQQLANV SQINKVRKDI ARLKTIIREK TGQL
Uniprot No.

Q&A

What is the genomic context of rpmC in Nitrosomonas europaea?

The rpmC gene (locus tag NE0409) in N. europaea encodes the 50S ribosomal protein L29 . It is positioned within a ribosomal protein gene cluster, closely associated with other ribosomal proteins including rpsC (NE0407, encoding ribosomal protein S3) . This organization is common in prokaryotes, where ribosomal proteins are often arranged in operons for coordinated expression. The genomic neighborhood includes several other ribosomal protein genes, reflecting the functional relationship between these components in ribosome assembly and function.

What protein interactions are documented for rpmC in Nitrosomonas europaea?

The ribosomal protein L29 in N. europaea functions within the ribosomal complex, participating in multiple protein-protein interactions essential for ribosome structure and function. String-db analysis indicates strong interactions with ribosomal proteins rpsJ (S10) and rplC (L3) with confidence scores of 0.999 for both interactions . These interactions are critical for proper ribosome assembly and function. The L29 protein likely participates in the ribosomal bridge structure between large and small subunits, similar to its homologs in other bacteria.

What expression systems are optimal for recombinant N. europaea rpmC production?

For recombinant expression of N. europaea rpmC, E. coli-based systems remain the workhorse due to their efficiency and scalability. Recommended methodology includes:

  • Codon optimization for E. coli expression, particularly important as N. europaea has a different GC content (approximately 50.7%) than typical E. coli expression strains

  • Use of BL21(DE3) or Rosetta strains to address potential rare codon issues

  • Temperature modulation (16-18°C post-induction) to enhance proper folding

  • Testing multiple fusion tags (His, GST, MBP) with preference for N-terminal MBP fusions to enhance solubility

For projects requiring native post-translational modifications, consider:

  • Pseudomonas-based expression systems (closer phylogenetic relationship)

  • Cell-free expression systems supplemented with N. europaea cellular extracts

What are effective purification strategies for recombinant N. europaea rpmC?

A multi-step purification protocol is recommended:

  • Initial capture: Affinity chromatography using the fusion tag (IMAC for His-tagged constructs)

  • Intermediate purification: Ion exchange chromatography (typically cation exchange at pH 6.5)

  • Polishing: Size exclusion chromatography

Key considerations include:

  • Buffer optimization (typically 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% glycerol)

  • Inclusion of reducing agents (1-5 mM DTT or 2-10 mM β-mercaptoethanol)

  • Tag removal assessment (Factor Xa or TEV protease depending on construct)

  • Concentration methods (centrifugal filters with appropriate MWCO)

How can site-directed mutagenesis of rpmC inform structure-function relationships?

Strategic mutagenesis targeting conserved residues provides valuable insights into protein function:

  • Identification of target residues through multiple sequence alignment across ammonia-oxidizing bacteria

  • Primer design guidelines:

    • 25-45 nucleotides in length

    • Mutation positioned centrally

    • Terminal G/C content of 40%+

    • Calculated Tm ≥78°C

  • Mutagenesis protocol optimization:

    • Use of high-fidelity polymerases (Pfu Ultra or Q5)

    • Extension times calculated at 1 min/kb

    • DpnI digestion (3-4 hours) to remove template DNA

  • Functional characterization through:

    • In vitro binding assays with other ribosomal components

    • Complementation studies in heterologous systems

    • Structural analysis via X-ray crystallography or cryo-EM

What approaches can characterize rpmC's role in N. europaea ribosome assembly?

To elucidate rpmC's role in ribosomal assembly:

  • Sucrose gradient ultracentrifugation analysis:

    • Prepare N. europaea lysate in ribosome buffer (20 mM HEPES pH 7.5, 10 mM MgCl₂, 100 mM NH₄Cl)

    • Fractionate on 10-40% sucrose gradients (78,000×g, 16 hours, 4°C)

    • Analyze fractions by immunoblotting with anti-rpmC antibodies

  • Pulse-chase experiments with isotope-labeled amino acids:

    • Pulse cells with ³⁵S-methionine

    • Chase with excess unlabeled methionine

    • Isolate ribosomal particles at various timepoints

    • Analyze incorporation of labeled rpmC into ribosomal particles

  • Cryo-EM structural analysis:

    • Purify intact ribosomes from N. europaea

    • Obtain high-resolution structures (3-4 Å)

    • Map the position and interactions of rpmC

    • Compare with available bacterial ribosome structures

How can researchers analyze evolutionary conservation of rpmC across ammonia-oxidizing bacteria?

Systematic evolutionary analysis methodology:

  • Sequence retrieval:

    • Obtain rpmC sequences from NCBI, UniProt, and specialized nitrifier databases

    • Include representatives from β-proteobacterial ammonia oxidizers (Nitrosomonas, Nitrosospira)

    • Include γ-proteobacterial ammonia oxidizers (Nitrosococcus)

    • Include archaeal ammonia oxidizers as outgroups

  • Multiple sequence alignment:

    • Primary alignment with MUSCLE or MAFFT algorithms

    • Manual curation of alignments

    • Conservation analysis using ConSurf or Rate4Site

  • Phylogenetic analysis:

    • Model testing using ProtTest or ModelFinder

    • Tree construction using Maximum Likelihood (RAxML or IQ-TREE)

    • Bayesian inference (MrBayes) for confidence assessment

    • Visualization with iTOL or FigTree

  • Selection pressure analysis:

    • Calculation of dN/dS ratios

    • Site-specific selection analysis (MEME, FUBAR)

    • Branch-site models to identify lineage-specific selection

How can MS/MS data of recombinant N. europaea rpmC be validated?

Robust mass spectrometry validation requires:

  • Sample preparation optimization:

    • In-gel or in-solution digestion protocols (trypsin, Lys-C, or combination)

    • Reduction/alkylation conditions (10 mM DTT, 55 mM iodoacetamide)

    • Desalting procedures (C18 stage tips or micro-columns)

  • Acquisition parameters:

    • Use of multiple fragmentation methods (CID, HCD, ETD)

    • Inclusion of technical replicates (minimum n=3)

    • Use of internal standards for quantification

  • Database searching:

    • Custom database including N. europaea proteome, contaminants, and decoys

    • Multiple search engines (Mascot, SEQUEST, MaxQuant)

    • False discovery rate control (target-decoy approach, 1% FDR)

  • Validation criteria:

    • Minimum of 2 unique peptides per protein identification

    • Manual validation of MS/MS spectra for critical peptides

    • Confirmation of post-translational modifications through neutral loss analysis

    • Targeted MRM/PRM for quantitation of specific peptides

How can solubility of recombinant N. europaea rpmC be improved?

Strategies to enhance recombinant rpmC solubility:

  • Fusion partner optimization:

    • MBP tag (42 kDa) offers superior solubility enhancement

    • SUMO fusion provides native N-terminus after cleavage

    • Thioredoxin fusion for smaller tag option

  • Expression condition modification:

    • Reduce induction temperature to 16-18°C

    • Lower IPTG concentration (0.1-0.2 mM)

    • Use auto-induction media for gradual expression

  • Buffer optimization:

    • Screen additives systematically (glycerol 5-10%, arginine 50-200 mM)

    • Test solubilizing agents (non-detergent sulfobetaines, low concentrations of urea)

    • Include stabilizing ions (Mg²⁺, K⁺) at physiological concentrations

  • Co-expression strategies:

    • Co-express with ribosomal protein partners (rpsJ, rplC)

    • Include molecular chaperones (GroEL/ES, DnaK systems)

    • Consider co-expression with RNA components for co-folding

What approaches can overcome challenges in generating antibodies against N. europaea rpmC?

Antibody development strategies:

  • Antigen design considerations:

    • Use full-length protein for polyclonal development

    • For monoclonals, identify surface-exposed epitopes (8-15 residues)

    • Use multiple peptide antigens to increase success probability

    • Consider carrier protein conjugation (KLH or BSA)

  • Production options:

    • Commercial custom services with guaranteed titer minimums

    • Research collaborations with immunology groups

    • Phage display technologies for difficult targets

  • Validation methodology:

    • Western blot against recombinant protein and N. europaea lysates

    • Immunoprecipitation followed by MS/MS confirmation

    • Immunofluorescence microscopy for localization

    • Pre-adsorption controls with antigen to confirm specificity

  • Troubleshooting approach:

    • Cross-reactivity assessment against related ribosomal proteins

    • Epitope mapping for monoclonal antibodies

    • Affinity purification against immobilized antigen

    • Storage optimization (add glycerol, aliquot, avoid freeze-thaw cycles)

How can researchers study rpmC function in vivo in N. europaea?

Methodological approaches for in vivo functional studies:

  • Genetic manipulation strategies:

    • Allelic exchange vectors designed for N. europaea

    • Conditional expression systems (inducible promoters)

    • CRISPR-Cas9 genome editing (with appropriate PAM sites)

  • Imaging approaches:

    • Fluorescent protein fusions (verify function preservation)

    • FISH with rpmC-specific probes

    • Super-resolution microscopy for sub-cellular localization

  • Physiological response measurements:

    • Growth rate comparisons in various conditions

    • Ammonia oxidation activity assays

    • Ribosome profiling and translation efficiency analysis

    • Stress response studies under oxidative or nitrosative stress

  • Interaction verification:

    • In vivo crosslinking followed by affinity purification

    • Bacterial two-hybrid systems

    • Co-immunoprecipitation with verified antibodies

    • Proximity labeling approaches (BioID, APEX)

How should researchers analyze contradictory data about N. europaea rpmC function?

Systematic approach to resolving contradictory findings:

  • Experimental design assessment:

    • Evaluate differences in growth conditions and media formulations

    • Consider strain variations and potential contamination

    • Review expression systems and construct differences

    • Assess environmental factors relevant to N. europaea (pH, ammonia concentration)

  • Statistical analysis framework:

    • Power analysis to ensure adequate sample sizes

    • Appropriate statistical tests based on data distribution

    • Multiple testing correction (Bonferroni, FDR)

    • Meta-analysis techniques for integrating multiple studies

  • Literature-based reconciliation:

    • Systematic review methodology

    • Weighted assessment based on methodological quality

    • Identification of mediating variables explaining discrepancies

    • Expert consultation with established nitrification researchers

  • Additional experimental approaches:

    • Design targeted experiments to directly address contradictions

    • Include appropriate positive and negative controls

    • Implement orthogonal methodologies to verify findings

    • Consider environmental factors specific to ammonia-oxidizing bacteria

What statistical approaches are appropriate for analyzing rpmC expression under different growth conditions?

Statistical analysis recommendations:

  • Experimental design considerations:

    • Minimum biological replicates (n=5)

    • Technical replicates for each biological sample (n=3)

    • Appropriate controls (housekeeping genes, reference conditions)

    • Time-course sampling for dynamic expression patterns

  • Normalization approaches:

    • For qPCR: ΔΔCT method with multiple reference genes

    • For RNA-Seq: TMM, DESeq2, or quantile normalization

    • For proteomics: Total spectral counts or SILAC ratios

  • Statistical testing framework:

    • Data normality assessment (Shapiro-Wilk test)

    • For parametric data: ANOVA with post-hoc tests

    • For non-parametric data: Kruskal-Wallis with Mann-Whitney tests

    • Mixed-effects models for complex experimental designs

  • Visualization recommendations:

    • Box plots showing distribution characteristics

    • Volcano plots for global expression changes

    • Heat maps for clustering similar expression patterns

    • Principal component analysis for multidimensional data reduction

Table 1: Recommended statistical approaches based on experimental design

Experimental DesignRecommended Statistical ApproachSoftware ToolsKey Considerations
Time-course experimentsRepeated measures ANOVA or mixed modelsR (nlme package), GraphPad PrismAccount for autocorrelation between timepoints
Multiple environmental conditionsTwo-way ANOVA with interaction termsR (car package), SPSSTest for interaction effects between factors
Dose-response studiesNon-linear regression, EC50 calculationGraphPad Prism, R (drc package)Consider appropriate curve fitting models
Transcriptomics dataDESeq2, edgeR, limma-voomBioconductor packagesAccount for multiple testing (FDR correction)
Proteomics dataMSstats, PerseusR packages, MaxQuantNormalization critical for accurate comparisons

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.